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a  b  s  t  r a  c t
Altered serum  and  plasma  microRNA  (miRNA)  expression  profiles  have  been observed  in numerous
human  diseases,  with a number of studies  describing circulating miRNA  biomarkers for  cancer diagnosis,
prognosis and  response  to treatment,  and recruitment  to  clinical  trials  for  miRNA-based drug  therapy
already  underway.  Electrochemical  detection  of biomarkers in urine  has  several significant advantages
over circulating biomarker  analysis  including safety, cost,  speed and ease of conversion  to the  point of care
environment. Consequently,  much  current  research  is  underway  to identify  urinary  miRNA  biomarkers
for  a variety of pathologies  including prostate and bladder  malignancies,  and renal  disorders.  We  describe
here a robust  method capable  of electrochemical  detection  of human urinary  miRNAs  at  femtomolar
concentrations using a  complementary  DNA-modified  glassy carbon  electrode.  A  miR-21-specific  DNA
hybridisation  probe  was immobilised  onto a glassy carbon  electrode  modified  by sulfonic  acid  deposition
and  subsequent  chlorination.  In our pilot  system, the  presence  of  synthetic  mature  miR-21  oligonu-
cleotides increased resistance  at  the probe surface  to electron transfer  from  the  ferricyanide/ferrocyanide
electrolyte. Response was  linear  for  10 nM–10 fM miR-21,  with  a limit  of detection of  20 fM,  and detection
discriminated  between  miR-21,  three point-mutated  miR-21 sequences,  and  miR-16.  We  then  demon-
strated  similar  sensitivity and  reproducibility  of miR-21  detection in urine  samples  from  5 human  control
subjects.  Our  protocol  provides a platform  for  future  high-throughput  screening  of miRNA biomarkers  in
liquid  biopsies.
© 2017  Published by  Elsevier  B.V.
1. Introduction
MicroRNAs (miRNAs) are single-stranded RNA transcripts, typi-
cally of 19–23 nucleotides in  length. Posttranscriptional regulators
of gene expression, miRNAs are currently estimated to target over
60% of the protein coding messenger (mRNAs) encoded by the
human genome. Aberrant circulating miRNA expression profiles
are associated with cardiovascular disease and numerous types of
malignancy, leading to the identification of novel miRNA biomark-
ers and miRNA-based therapeutic approaches, with recruitment to
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clinical trials for cancers of the brain, breast and liver underway
[1,2].
In  contrast to blood and biopsy collection, urine samples
are obtained non-invasively, with minimal inconvenience to the
patient. In addition, urine sampling is quicker and safer, leading to
reduced test cost and ease of adoption for biochemical laboratory
and/or point of care testing. Consequently, numerous studies are
underway to identify urinary miRNA biomarkers for renal disorders
[3,4] as well as bladder and prostate cancers [5,6].
We have recently shown that urinary miRNAs are stabilised by
association with i) extracellular vesicles such as exosomes and ii)
argonaute 2 protein, and have optimised RT-qPCR-based methods
for their isolation and detection [7].  Here, we  report the mea-
surement of human urinary miRNA molarity using an optimised
electrochemical detection method suitable for development as a
point of care test.
Current miRNA detection methods include Northern blotting
[8],  RT-qPCR [4,7],  microarray [9], surface plasmon resonance [10]
http://dx.doi.org/10.1016/j.snb.2017.06.069
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Scheme 1. Schematic representation of the fabrication and operation procedure of the biosensor: a, b) A naphthalene sulfonic acid is electrochemically deposited via cyclic
voltammetry onto a  glassy carbon electrode surface and c)  subsequently chlorinated using PCl5 . d) A DNA oligonucleotide with complementary sequence to the  miRNA target
(shown in red) is then added and an electrochemical analysis in ferri/ferrocyanide performed. e) Finally, the electrode is  hybridised with the target miRNA (blue) and a second
comparative electrochemical analysis performed. (For interpretation of the references to  colour in this figure legend, the reader is  referred to  the web version of this article.)
and fluorescence-based techniques [11]. These require lengthy pro-
tocols together with highly specialised analysts and equipment,
limiting their potential use in point of care diagnostics. Detection
of nucleic acids and other biomolecules by  aptamer-based elec-
trochemistry has been the focus of much recent research interest
[12–14]. Consequently, a  number of recent electrochemical miRNA
detection studies have demonstrated that high levels of sensitivity
can be achieved rapidly and cheaply [15–18].  However, many of
these methods incorporate signal amplification via precious met-
als and nanoparticles [19], enzymes [20,21], or four-way junctions
[22], or a combination strategy combining fluorescence and elec-
trochemistry [23],  and thus remain reliant on specialist knowledge
and equipment.
By contrast, following probe fabrication our method requires
minimal liquid handling in a  straightforward dipstick-style test.
Firstly, a glassy carbon electrode is modified with a commercially
available naphthalene sulfonic acid derivative to  produce a  reac-
tive surface, then a DNA probe is  attached that will hybridise with
complementary target miRNA, as shown in Scheme 1. Electrochem-
ical measurements can then be performed, and the target miRNA
concentration obtained. Single-stranded DNA detection has been
described elsewhere [24].
We have recently described a  robust method to  extract and
amplify miRNAs from human urine [7].  The use of urine as the
sample matrix removes the need  for invasive blood sampling pro-
cedures used previously [25,26]. The electrochemical detection
procedure we describe herein requires only minimal urine sample
treatment and does not require extensive miRNA extraction pro-
cedures, toxic and expensive chaotropic reagents, or solvent phase
separations, and is  therefore more readily applicable to the point
of care environment.
2. Experimental
2.1. Reagents and chemicals
A glassy carbon electrode (3 mm diameter) was  obtained
from BASi
®
(Lafayette, USA). All DNA oligonucleotides were syn-
thesised by Sigma-Aldrich Co. Ltd. (Gillingham, UK). Potassium
ferri/ferrocyanide, bovine serum albumin (BSA) and Tris HCl were
obtained from Sigma-Aldrich. RT-PCR materials were purchased
from Qiagen
®
(Manchester, UK). HPLC purified RNA was purchased
from IDT
®
(Leuven, Belgium), the remaining buffer ingredients and
1-amino-2-naphthol-4-sulfonic acid were purchased from Fisher
Scientific
®
(Loughborough, UK). RNase free water was  produced
by overnight treatment with 0.1% v/v DEPC and subsequent auto-
claving. The DNA and RNA were dissolved in  RNase free pH 8.0
TMD  buffer consisting of 50 mM Tris-HCl, 20 mM MgCl2 and 1 mM
dithiothreitol. DNA and RNA samples were stored frozen at −80 ◦C
and denatured at 80 ◦C for 2 min  prior to use, sequence data are
provided in the supplementary information (Supplementary table
S1).
2.2. Instruments
Initial electrochemical measurements to determine sensitivity
and optimise sulfonic acid electrodeposition were performed using
a  PARSTAT-2273 potentiostat/galvanostat and Powersuite
®
soft-
ware from Princeton Applied Research
®
. The urine analyses were
performed using a  PalmSens3
®
potentiostat supplied by  Alvatek
®
(Tetbury, UK) and data processing performed using PSTrace 4.7 and
EIS spectrum analyser.
2.3. Electrode preparation and modification
Initially, the electrode was prepared following a  modified ver-
sion of the Wang method [24].  Briefly, a  glassy carbon electrode
was polished to a mirror-like finish using 3 m, 1 m diamond pol-
ish and 0.05 m alumina polish, and then sonicated for 90 s each
in  acetone, ethanol and water. The electrode was submerged in  a
solution of 1-amino-2-naphthol-4-sulfonic acid (12 mL, 10 mM)  in
PBS buffer (25 mM,  pH 7.0). This was  then prepared as a 3 elec-
trode cell consisting of the glassy carbon electrode as the working
electrode, platinum wire as the auxiliary electrode and an Ag/AgCl
reference electrode. Cyclic voltammetry was  performed between
1.5  V and −0.5 V at a  rate of 20 mVs−1 to induce electrodeposition
until a  steady voltammogram was obtained (8 cycles). The elec-
trode was rinsed with distilled water for 30 s,  shaken to remove
excess water and placed in  a  5 mL  vial containing PCl5 (16.7 mg,
40 mM)  in  acetone (2 mL)  for 30 min  [24]. A 10 L, 1 M solution of
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Fig. 1. Change in coulometric response between the electrode modified with complementary DNA strand alone and following RNA incubation (Q)  with log10 miR-21
concentration (M), performed in triplicate. The calculated limit of detection is  2.0 × 10−14 M  (20 fM)  and the regression coefficient (Pearson) is  98%.
DNA oligonucleotide with a  sequence complementary to the target
miRNA, dissolved in TMD  buffer (50 mM Tris-HCl, 20 mM MgCl2,
pH 8.0) was heated to a  denaturation temperature of 80 ◦C for
2 min  (calculated Tm 74.7 ◦C [27]). This solution was then dropped
onto the glassy carbon surface and dried under vacuum at 80 ◦C for
90 min. The electrode was rinsed for 30 s in TMD buffer and electro-
chemical measurements were taken for use as the initial data points
(see 2.4 Electrochemistry). The electrode was then incubated with
shaking, for 30 min  at 50 ◦C (Supplementary Fig. S26) in  the desired
concentration of target miRNA in  TMD  buffer (1 mL), rinsed with
buffer and measurements taken.
2.4. Electrochemistry
Analyses for synthetic hsa-miR-21-5p (miR-21) were performed
using a PARSTAT-2273 potentiostat and Powersuite
®
software,
urine analyses were performed using a  PalmSens3
®
potentiostat
and data processing performed using PSTrace 4.7 and EIS spec-
trum analyser. Electrochemical measurements were taken before
and after probe hybridisation by  i) running cyclic voltammograms
between 0.6 V and −0.3 V at a  scan rate of 100 mV  s−1 (data not
shown) ii) coulometry performed at 0.3 V for 0.1 s, 0.0 V for 2 s and
0.5 V for 2 s and iii) an electrical impedance spectrum (EIS) run at
a DC potential of 0.23 V between frequencies of 0.01 Hz to 10 kHz
with an AC amplitude of 5 mV.  All measurements were taken in
5 mM K4[Fe(CN)6]/5 mM  K3[Fe(CN)6]  in  0.1 M  KCl. Q  is defined as
the change in coulometry signal upon probe hybridisation.
2.5. Sodium chloride matrix effects
To investigate sodium chloride matrix effects, the required con-
centration of miRNA was prepared as before (10−10 M,  1 mL)  and
NaCl was added to  a  final concentration of 3 mg/mL  or 10 mg/mL.
The DNA modified electrode was immersed in the miRNA solution
at 50 ◦C for 30 min  with shaking and, after rinsing with TMD  buffer,
the electrochemical measurements were recorded.
2.6. Protein matrix effects
BSA (3 mg)  was added to miRNA (10−10 M) in TMD  buffer (1 mL)
and the solution shaken to  ensure dissolution. Proteinase K (1 mg)
and CaCl2 (1 mg)  were added, and the mixture incubated at 50 ◦C
for 1 h. The solution was incubated with a  DNA modified electrode
at 50 ◦C for 30 min  with shaking before rinsing in  TMD  buffer and
recording the final electrochemical measurements.
2.7. Urine samples
Five urine samples, from anonymised donors, were collected
from healthy donors according to guidelines and permission from
the Wales Kidney Research Tissue Bank and stored at −80 ◦C prior
to use. Prior to  analysis, proteinase K (10 L, 20 mg/mL) and CaCl2
(1 mg)  were added to  urine (490 L) and incubated at 50 ◦C for
10 min. The sample was then passed through a  10 kDa spin filter
at 14,000 rcf (12,300 rpm) for 20 min  at 20 ◦C.
2.8. Reverse transcription-quantitative PCR (RT-qPCR) analysis
A serial dilution series of miR-21 between 10−8 and 10−14 M was
prepared in  TMD  buffer. As  we have described in detail elsewhere
[7],  RT-qPCR was then carried out on these dilutions directly, or
following extraction using a  Qiagen
®
miRNA extraction kit. Aliquots
from the 5 urine samples described above were processed using the
Qiagen
®
miRNA extraction kit. Where appropriate extracts were
frozen at −80 ◦C  prior to  analysis using standard RT-qPCR protocols
(vide supra).
2.9. Data analysis
All impedance spectra were processed using freely available EIS
spectrum analyser [See EIS Spectrum Analyser]. Coulometry and CV
data were processed using the software supplied with the respec-
tive potentiostat.
3. Results and discussion
3.1. Initial sensitivity testing of the sensor
This procedure was  first performed using solutions of  synthetic
target miR-21 (Supplementary table S1). The electrode was tested
by  immersion in a  dilution series of synthetic miR-21 solutions
spanning 10−8 M (10 nM)  to 10−14 M (10 fM). The turning point
from each double step coulometry trace was used for compari-
son. Changes in  coulometric responses (Q) between the electrode
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Fig. 2. Change in coulometric response (Q)  with increasing number of mismatches compared to target miR-21 sequence, performed in triplicate at  10 nM.  Shown from
left  to right, the fully complementary target (blue), 1 mismatch sequence (orange), 2 mismatch sequence (gray), 3 mismatch sequence (yellow), miR-16 (dark blue). (For
interpretation of the references to  colour in this figure legend, the reader is  referred to  the web version of this article.)
modified with a DNA strand alone, and following DNA/RNA hybrid
formation, are reported herein due to their linear relationship
with log10 [miR-21], regression coefficient of 0.984, and low vari-
ance in Q  when performed in triplicate. The change in  signal
may  be due to formation of RNA/DNA hybrids that inhibit pas-
sage of ferro/ferricyanide to the electrode surface by increasing
steric occlusion and electrostatic repulsion. These replicates were
performed using a  freshly prepared electrode surface for each mea-
surement, however electrodes could also be reused up to  two  times
by heat denaturation to  remove the RNA with little degradation in
the subsequent response (Supplementary Fig. S2). Fig.  1 shows the
linear relationship between the charge difference, Q, with log10
of the miRNA concentration. By extrapolation to  zero signal, the
method can potentially detect miR-21 at a  concentration of 6 fM.
Based upon the standard deviation of measurements of 4 samples
containing no RNA, the limit of detection is  determined to be 20
fM, which is in the same order of magnitude as the 72 fM quoted
by Wang et al. for DNA [24],  and close to the 10 fM for RNA sug-
gested by Wu et al. and Tran et al. [28,29]. The results of electrical
impedance spectroscopy, and an overlay of the raw data are shown
in the supporting information (Supplementary Figs. S3-5). As a sec-
ondary technique, impedance spectroscopy data were robust, with
a  similar sensitivity to  coulometry, albeit with lower R2. Differential
pulse voltammetry experiments (not shown) were also performed,
however these showed an unacceptable level  of noise.
3.2. Specificity of the sensor
Since mature miRNAs are very short transcripts, and different
miRNAs may  vary by only 1 or 2 nucleotides, the selectivity of
complementary DNA:target miRNA hybridisation is critical. To test
selectivity, we compared the electrochemical signal response using
concentrated (10 nM) solutions of synthetic miR-21 with 1, 2 or 3
central and/or peripheral nucleotide changes as well as compar-
ison with the hsa-miR-16-5p (miR-16) sequence (Supplementary
table S1). Fig. 2 (Supplementary Fig. S6) shows that the presence
Fig. 3. Change in coulometric response (Q) with concentration of miR-21 (blue circles) and miR-16 (orange triangles) with anti-miR-21 and anti-miR-16 DNA probes
respectively. Performed in triplicate in a solution of 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl. (For interpretation of the  references to  colour in this figure legend, the reader
is  referred to the web version of this article.)
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Fig. 4. (A) Variation of CT  value with miR-21 concentration. (B) Comparison of miR-21 concentration values determined using electrochemical Q (blue, left) and RT-qPCR
data  (orange, right) in urine samples from 5 different subjects. (For interpretation of the references to colour in this  figure legend, the  reader is  referred to  the web version
of  this article.)
of one mismatched nucleotide results in  a  > 60% reduction in Q,
even at this elevated miRNA concentration. Additional mismatches
led to further reductions: 2 mismatches by  76%, 3 mismatches by
86% and miR-16 by  90%. These data suggest that our  method will be
both highly selective and sensitive at the low miRNA concentrations
found in human urine [30,31].
For effective point of care use, our biosensor should be suffi-
ciently flexible to detect and quantify different miRNA targets. We
therefore prepared a  probe using an oligonucleotide complemen-
tary to miR-16, and plots of Q  versus log10 [miR-16], obtained
as before, were overlaid with the corresponding miR-21 results
(Fig. 3, Supplementary Fig. S7).  Within error the data points are
almost coincident, leading to very similar gradients (5.87 ±  0.33
and 5.15 ± 0.23 respectively) in the plots and confirming that
the biosensor may  readily be manipulated to  quantify different
miRNA targets. Sensors retained their ability to detect miRNA after
treatment at elevated temperatures of up to 50 ◦C for 24 h (Supple-
mentary Fig. S8).
3.3. Urine analogues, human urine and control experiments
We then investigated miR-21 detection using our biosensor in
urine mimic  aqueous solutions containing salt, urea and protein
(bovine serum albumin). While salt and urea show little detrimen-
tal effect on the electrochemical response (Supplementary Figs.
S9–S11), the presence of protein results in a  profound increase
in  surface impedance (Supplementary Fig.  S12). This effect can be
attributed to  extensive protein adsorption to the electrode surface,
therefore interfering with the DNA/RNA response. To digest uri-
nary proteins without full chemical-based miRNA extraction, we
incubated urine samples with proteinase K at 50 ◦C for 10 min, and
a response similar to that observed in the absence of  protein was
seen (Supplementary Fig. S13).
For miRNA analysis in human urine, we wished to com-
pare the electrochemical detection protocols described here with
our  established RT-qPCR-based methodology. Initial attempts at
electrochemical detection of miR-21 in  human urine showed
an increase in charge transfer resistance at the electrode sur-
face that we attributed to proteinaceous electrode fouling. We
have shown previously that exogenous miRNAs added to human
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urine are degraded rapidly as a result of native RNase activity
[7]. We  therefore followed the above proteinase K  digestion by
spin-filtration through a  10 kDa filter to separate miRNAs from
remaining high molecular weight biomolecules including RNases,
and data obtained after this step indicated an absence of fouling.
Control experiments (Supplementary Figs. S14-16) in  which miRNA
was sequestered by  a  complementary peptide nucleic acid (PNA),
or  intentionally cleaved by  addition of RNase A, indicated that the
responses observed were selective for miR-21 and not due to other
components of the urine matrix. An  anti-miR-21 probe incubated in
urine treated with proteinase K,  filtered and then mixed with a PNA
complementary for miR-21 gave a  negligible response (Fig. S14).
When the same solution was tested with an anti-miR-16 probe, a
significant change in CV response was obtained (Fig. S15). Finally,
an anti-miR-16 probe electrode incubated in  a RNase-treated urine
solution gave a negligible response (Fig. S16), but following fil-
tration and the addition of synthetic miR-16, the response once
again changes significantly. These results provide further evidence
that our pre-treatment procedure using proteinase K and filtration
effectively prevents protein fouling of the electrode while main-
taining its miRNA response.
For direct comparison of RNase-free electrochemical- and RT-
qPCR-derived miR-21 concentration estimates, we prepared a
dilution series of synthetic miR-21 in  RT buffer solution (MgCl2, Tris
HCl) that showed a  linear relationship between RT-qPCR thresh-
old cycle and −log10 [miR-21]. We  then compared electrochemical
and RT-qPCR miR-21 detection in 5 human urine samples (Supple-
mentary Figs. S17–S23). RT-qPCR data for urinary miR-21 extracted
using an extraction kit were then used to calculate urinary miR-21
concentrations from the calibration curve. MiR-21 was chosen since
previous work has shown increased detection of this sequence in
urine in chronic kidney disease and acute kidney injury [32,33].
Fig. 4A and B show the overlaid results of both the RT-qPCR con-
centration and coulometry analyses.
Despite obtaining overall similarities in  concentration ratios for
each sample with both techniques, our biosensor detected higher
miRNA concentrations than the RT-qPCR analysis. Furthermore,
control experiments using known concentrations of synthetic miR-
21 produced RT-qPCR data suggesting that the recorded drop in
concentration shown in  the PCR analysis resulted from losses
during sample preparation (Supplementary Figs. S24-25). Since
electrochemical detection requires one pipetting step and no chem-
ical extractions, this method may  avoid concentration losses and
thereby increase sensitivity. The urinary miRNA concentration
range we detected (10−9–10−11 M)  falls well within that part of
the calibration plot that shows good reproducibility.
Our technique has thus provided a  measure of urinary miRNA
molarity, and our biosensor has potential for use in  future analyses
of urinary miRNAs as disease biomarkers.
4. Conclusions
In conclusion, we have designed a  highly sensitive and specific,
straightforward electrochemical biosensor assay for the detec-
tion and quantification of urinary miRNAs requiring minimal
sample treatment. The electrochemical data obtained from the uri-
nary analysis produced comparable results to RT-qPCR detection,
with increased sensitivity, and the biosensor selectively detected
two different miRNA sequences. Future investigations using this
procedure to quantify urinary miRNAs in  healthy and diseased indi-
viduals will provide insight into its viability as an applied biosensor.
Finally, to expedite commercialisation of our biosensor assay, we
are currently testing our method using disposable electrodes that
could be supplied pre-modified with DNA to simplify and accelerate
the electrochemical analysis in  a  point-of-care setting.
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